J. David Legan, PhD
Director of Science
David earned his Ph.D. in Food Technology from the University of Reading in the UK by modeling the ecology of mixed microbial populations, and then moved to Campden BRI in a variety of microbiological food safety research and client service roles. During that time, he was project lead for the Bacillus component of the UK’s pathogen modeling program. He moved again to Nabisco Research in New Jersey where he ran the corporate microbiology lab and developed a program of preservation technology development and microbial modeling. After the Kraft Foods acquisition, he moved to Chicago to work on Food Safety and Preservation research, and through modeling and validation studies:
- Optimized Oscar Mayer’s use of lactate and diacetate and their naturally cultured alternatives as Listeria-control agents in Ready to Eat meats
- Specified process conditions central to Oscar Mayer’s commercial launch of High Pressure Pasteurization of naturally cured RTE meats
David had responsibility for the Kraft cultures R&D group, developed a partnership to explore microwave sterilization leading to several patents, and led a program that developed an internal proprietary natural antimicrobial commercialized in several Kraft products. Technologies from his group supported approximately $4 billion in annual sales.
After years as a microbiology "client", he is now back in the "provider" role as Director of Science at Eurofins Microbiology Laboratories, Inc., by way of the Covance Food Solutions group based in Madison, WI, which he joined in 2016. In this role, he ensures appropriate method validation, explores new testing technologies, and fields multiple complicated food microbiology questions.
Products that his team has evaluated or developed and launched include:
- The 3M MDS platform in the Madison microbiology laboratory
- Flow cytometry for enumeration of probiotics
- Strain-level confirmation of probiotic identification using the polymerase chain reaction (PCR)
- Next-generation sequencing using the Oxford Nanopore Technologies GridION sequencing platform for microbial identification and microbiome analysis
Below are resources from David:
Bacillus consists of a wide range of species from pathogenic types to beneficial bacteria. Bacillus coagulans, specifically, is commonly used in various products due to its survivability of many processing conditions as well as long shelf life needs. So, how would you test for the pathogen, Bacillus cereus, in a product containing Bacillus coagulans? Our Principle Scientist, Megan Brown, discussed more on this topic and what to keep in mind.
Clinical studies suggested that glucosamine has the potential to be used to relieve joint pain causing by Osteoarthritis and Rheumatoid Arthritis. We offer several methods for the characterization and quantification of glucosamine in dietary supplements and ingredients. The selection of the testing technique is dependent on the sample matrix, formulation, and the method used when establishing product specifications. Read through this article to learn more about the use of glucosamine in supplements and the options for testing methods.
In this article get answers to some frequently asked questions about sterol testing. Learn how the method is run, what matrices it is suitable for, and more.
Eurofins Craft Technologies Offers Vitamin K-1 & K-2 Testing to Support Trending Immunity Foods & Supplements.
Eurofins now offers validated methods for chondroitin testing on sports nutrition and joint health supplements.
In this blog post Eurofins Analytical Services Manager Jeff Stassi explains why it is so important to set specifications for dietary supplements.
In this blog post Jeff Stassi, Eurofins Analytical Services Manager, gives three tips on how to make sure that you are partnering with a testing laboratory that you can trust, and that has the expertise required to analyze your product.
In this presentation, USP and Eurofins Microbiology provided an overview of USP microbiology methods tests for microbial contamination in dietary supplements, CBD/hemp products, and probiotics. The session included an in-depth discussion regarding the importance of suitability testing, and a comparison of USP methodology to AOAC/FDA BAM methodology. USP also provided an update on new USP chapters and shared insight on what is on the horizon for USP methods.
In this document, you will see the list of chemicals on the Proposition 65 list and learn how Eurofins is prepared to help you develop your products, qualify your supply chain, and conduct ongoing quality control to minimize the risk of incomplete labeling.
This document describes the nutrition and supplement facts labels changes.
